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890Atrial tachyarrhythmias (AT) re-
present the most common clinical
heart rhythm disorder (1). The
management of AT, including
those arising in patients under-
going atrial ﬁbrillation (AF) (2)
ablation, is challenging due to
various mechanisms and ubiq-
uitous locations. Twelve-lead elec-
trocardiography (ECG) is the
standard-of-care technology to
diagnose theorigin andmechanism
of atrial tachyarrhythmia arising inpatientswith orwithout previous ablation prior to clinical cardiac
electrophysiological (EP) intervention (3,4). However, the 12-
lead ECG is limited in diagnosing the mechanisms and locali-
zation of the arrhythmias, particularly in the setting of previous
ablation and often requires complicated algorithms (5).
See page 898
With the advent of percutaneous transvascular catheteriza-
tion and electrical mapping systems in the EP lab, it has
become possible to simultaneously evaluate, diagnose, and
treat the arrhythmias. In the last 2 decades, technological
advances have resulted in the development of multiple,
sophisticated, high-density and/or 3-dimensional (3D)
mapping systems for the diagnosis and understanding of
different types of atrial arrhythmias (6,7). These have helped to
improve existing and evolve novel approaches to treat simple
and complex atrial rhythmdisorders.However,most advanced
mapping systems rely on serial, beat-by-beat arrhythmia
mapping, which requires 10 to 30 min for acquisition and
additional post-processing to understand the mechanism of
AT. In addition, these systems provide mapping information
only during the invasive procedure; thereby, they are lacking
the advantage of allowing physicians to plan the procedure in
advance for better management of complex arrhythmia.
Therefore, diagnosing AT may be a challenge, leaving room
for improvement in planning invasive EP study and subse-
quent ablation.
Electrocardiographic mapping (ECM) is a novel 3D, 252-
lead, surface ECG-based noninvasive epicardial mapping
system that provides global chamber mapping in a single beat
(8,9). We aim to evaluate the potential of this mapping system
in a series of patientswithATarising in various clinical settings.
Methods
Study population. Fifty-two patients with clinical AT
(including post-AF ablation and post-atriotomy) from 3 centers
(in France and the United States) consented to participate in the
study, which was approved by the institutional review commit-
tees of all the participating centers. All patients underwent the
ECM procedure (CardioInsight Inc., Cleveland, Ohio). The
accuracy of the system in diagnosing the arrhythmia mechanismand location of arrhythmia during AT was determined by
comparison with invasive mapping and conﬁrmed by successful
ablation in all patients. Invasive EP mapping was performed
using conventional electrogram and 3D electroanatomical
mapping system (Carto XP, Biosense Webster, Diamond Bar,
California; or NavX, St. Jude Medical Inc., Minneapolis, Min-
nesota) guidance. ECM was considered accurate when the
detection of the clinical target by ECM matched with that ob-
tained on invasive EP mapping and subsequently conﬁrmed by
successful ablation. A schema of biatrial anatomy was prepared
based on biatrial epicardial geometry obtained from a computed
tomography scan.The schematic was divided into 20 anatomical
segments (Online Fig. 1). The segmentwise location of the
source of each centrifugal AT was indicated on the schematic.
Similarly, the macro–re-entrant AT involving 3 or more
contiguous segments were represented by drawing the tachy-
cardia circuit on the schematic.
Electrocardiographic mapping. The signal acquisition from
the patient and subsequent computational methods used in the
reconstruction of ECM maps using multiple torso electrodes
have been previously described (8). Brieﬂy, a 252-electrode vest
is applied to the patient’s torso and connected to the ECM
system and surface potentials are recorded. It is followed by
a noncontrast thoracic computed tomography scan to obtain
high-resolution images of the heart and the vest electrodes. The
electrode positions and 3D epicardial biatrial geometry are
obtained via segmentation from the computed tomography
images. The system reconstructs epicardial potentials and uni-
polar electrograms from torso potentials during each beat per
cycle using mathematical reconstruction algorithms. Details of
the mathematical methods have been provided in previous
publications (9,10). Activation maps are computed using
traditional unipolar electrogram intrinsic deﬂection-based
(-dV/dTmax) method. In addition, a novel directional activa-
tion map using electrogram morphology and local propagation
between adjacent electrograms facilitated the analysis of ECM.
All ECM data were analyzed by 2 operators systematically
in a stepwise manner as follows:
1. A window of 1 tachycardia cycle involving distinct
tachycardia P waves and/or the tachycardia-initiating
beat, if available, was selected. The window was
selected such that the beginning coincided with the
predominant deﬂection on the body surface signal in
the relative location of the anterior precordial leads. If
additional cycles were available, signal averaging and
speciﬁc algorithm-based analyses were undertaken.
2. Between the two atria, we grossly identiﬁed and distin-
guished the passively activated atrium (positive
morphology [RorRs] of unipolar electrograms) from the
active (driving) chamber (negative morphology [QS or
Qr] of unipolar electrograms) based on the selected
window of interest.
3. The tachycardia mechanism was deﬁned as “macro–
re-entrant” (which includes perimitral, cavotricuspid
isthmus-dependent, roof-dependent, and around surgical
Table 1 Baseline Characteristics (N ¼ 52)
Age, yrs 61  11
Sex
Male 42 (81)
Female 10 (19)
Hypertension 16 (31)
Diabetes 06 (12)
Cerebrovascular accident 04 (08)
Structural heart disease 18 (35)
Antiarrhythmic drugs attempted, per patient 1.2  0.9
Previous AF ablation 27 (52)
Linear lesions 14 (52)
Left atrial dimension, mm 43  5
Left ventricular ejection fraction, % 52  14
Atrial tachycardia cycle length, ms 284  85
Values are mean  SD or n (%).
AF ¼ atrial ﬁbrillation.
Table 2
Accuracy of Electrocardiomapping in Deﬁning
Ablation Targets
Electrophysiological
Laboratory Diagnosis n
Previous
AF Ablation
ECM
Correctly
Diagnosed
Diagnostic
Accuracy, %
Re-entry
Cavotricuspid
isthmus-
dependent
18 2 18 100
Roof-dependent 3 3 3 100
Perimitral 5 5 1 20
Around the scar 1 0 1 100
Total 27 10 23 85
Focal
Right atrial 4 2 4 100
Left atrial 15 11 15 100
Septal 2 0 2 100
Total 21 13 21 100
Subtotal 48 23 44 92
Inevaluable 4 4 d d
Grand total 52 27 d d
Accuracy for unablated atria: 100% (25 of 25); accuracy for previously ablated atria: 83%
(19 of 23).
AF ¼ atrial ﬁbrillation; ECM ¼ electrocardiomapping.
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891scar tachycardias) or “centrifugal.” In centrifugal AT, the
location of arrhythmia source was determined. In general,
if an activation map of AT encompassed >75% of the
cycle spread over 3 or more atrial segments in a re-entrant
fashion around a large central obstacle, then the AT was
diagnosed as macro–re-entrant. On the other hand, focal
AT were diagnosed based on the presence of centrifugal
spread of activation from small source (focus) (11).
Invasive EP study. After pre-procedural ECM, all the
patients were subjected to invasive EP study. The invasive
operator was blinded to the noninvasive diagnosis. Two or 3
vascular sheaths were inserted into the right femoral vein
under lignocaine/bupivacaine local anesthesia. A steerable
decapolar catheter (5 mm interelectrode spacing, Xtrem,
Sorin Medical, Montrouge, France) or octapolar catheter
(2-5-2 mm, EPXT, Bard Electrophysiology, Lowell,
Massachusetts) was placed in the coronary sinus. Access into
the left atrium, whenever required, was gained with trans-
septal puncture (Adult BRK 71-cm needle, St. Jude Medical)
using ﬂuoroscopic and hemodynamic (pressure) guidance
and conﬁrmed by left atrial contrast atriogram. A 2-in-1
technique was used to pass a long sheath (St. Jude Medical
SL0, 63-cm) and a 3.5-mm open-irrigated-tip catheter
(ThermoCool D/F curve, Biosense Webster) across the
septum into the left atrium via a single puncture. The long
sheath was continuously perfused with heparinized saline at
100 to 200 ml/h. Following the completion of transseptal
access, a weight-based bolus dose of unfractionated heparin
was administered. The participating centers followed their
institutional protocol to maintain adequate anticoagulation
guided by activated clotting time (250 s, 350 to 400 s).
Sedation (level 3 on Ramsay sedation scale) and analgesia
was determined by hospital protocol and consisted of:
1) midazolam, 0.02 mg/kg prior to femoral puncture;
2) morphine sulfate, 0.1 mg/kg pre-procedurally up to
a maximum of 0.2 mg/kg or fentanyl 50 mg bolus with or
without 3) supplementary analgesia (sufentanil) providedunder
anesthetic supervision. Monitoring with noninvasive blood
pressure, digital pulse oximetry, and/or CO2 end tidal volume
was performed continuously throughout the procedure.
Surface electrocardiograms and bipolar intracardiac electro-
grams were continuously monitored with the use of Lab
System Pro (Bard Electrophysiology) or Cardiolab System
(GEMedical Systems, Milwaukee, Wisconsin). Signals were
sampled at 1 kHz and ﬁltered at 0.1 to 50 Hz for surface
electrocardiograms and 30 to 250 Hz for intracardiac signals.
Ablation parameters. Ablation was performed using a 3.5-
mm externally irrigated-tip catheter (Thermocool, Biosense-
Webster). The ablation parameters were regulated depending
upon the site of ablation. In general, power delivery ranged
from 20 to 35 W with target temperature usually below
43C (maximum 45C) achieved using manually adjustable
irrigation rates of 5 to 60 ml/min (0.9% normal saline via
a Cool Flow pump) (Biosense Webster, Diamond Bar,
California) or with a ﬁxed ﬂow rate of 17 ml/min. Theendpoint was termination of tachycardia during ongoing
ablation. In patients who underwent pulmonary vein isolation
previously, complete electrical isolation of all pulmonary veins
was ensured before the end of the procedure and additional
ablation was performed, if required. If linear lesions were
deployed and gaps were discovered, further ablation was
undertaken in paced/sinus rhythm until bidirectional block
was ascertained.
Statistical analysis. Continuous data are reported as mean
 SD and categorical data are reported as percentages
(Microsoft Excel software, Microsoft Corporation, Red-
mond, Washington).
Results
Baseline characteristics. The baseline clinical characteristics
of 52 patients are provided in Table 1. The mean age was
Figure 1 Cavotricuspid Isthmus-Dependent AT
(A) A 12-lead electrocardiogram of clinical tachycardia from a patient who previously underwent extensive ablation for atrial ﬁbrillation. (B) An isochronal activation electro-
cardiomap of counterclockwise cavotricuspid isthmus-dependent atrial tachycardia (AT). Typically, the interatrial groove is activated from below upward followed by sequential
activation of the right atrial free wall from above downward. The left atrial breakthroughs at the coronary sinus and the Bachmann bundle area result in septal-to-lateral activation
of the anterior and posterior left atrium. The morphology of the virtual unipolar electrograms displayed from 6 atrial sites distributed around the tricuspid annulus concurs with
this activation pattern. The color of the unipolar electrogram corresponds to the color of the spot marked on the biatrial geometry. Online Video 1 shows an isopotential map of
this AT. On the color scale, the earliest activation site is red and the latest is purple. The color map shows 160 ms of activation. The cycle length here is 244 ms. The remainder
of the cycle length is within the slow conduction zone (cavotricuspid isthmus), on either side of which purple meets red. (C) Intracardiac electrograms from the isthmus and
coronary sinus recorded during the ablation of cavotricuspid isthmus-dependent AT. (D) Postero-anterior ﬂuoroscopic image showing the location of intracardiac catheters.
LAA ¼ left atrial appendage; MA ¼ mitral annulus; RAA ¼ right atrial appendage; SVC ¼ superior vena cava; TA ¼ tricuspid annulus.
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89261 11 years and there were 42male patients. Structural heart
disease was present in 18 (35%), and 27 (52%) patients had
previous AF ablation (including surgical ablation in 1 patient).
Two patients had undergone bilateral lung transplantation.
The mean cycle length of the clinical AT was 284  85 ms.
Electrophysiological diagnosis. All patients were ﬁrst
mapped at the bedside using ECM, followed median 1 day
(interquartile range 1 to 7) after by invasive mapping and
ablation. In the majority of patients, the system processed
the data and generated the maps in less than 5 min. The
ECM diagnosis was evaluable in 48 of 52 patients in whom
there was conﬁrmed EP diagnosis and successful ablation. In
4 patients, clinical AT converted to another rhythm (AT
and AF in 1 each and sinus in 2) before invasive mapping
was completed, and therefore, these patients were excluded
from the comparative analysis (Table 2).
Types of atrial tachycardia. Out of 48 evaluable clinical AT,
27ATwere diagnosed in theEP laboratory asmacro–re-entrant
and 21 as centrifugal arrhythmias (Online Fig. 2). All of them
were successfully terminated by ablation resulting in sinusrhythm in 44 or to another AT in 4. ECM identiﬁed the
mechanism of AT as macro–re-entry versus centrifugal acti-
vation in 44 of 48 (92%) patients (Table 2).
RE-ENTRANT ATRIAL TACHYCARDIA. Among 27 re-entrant
AT diagnosed invasively, there were 18 cavotricuspid
isthmus-dependent, 5 perimitral, and 3 roof-dependent AT
(Figs. 1 to 3, respectively; see also Online Videos 1, 2, and 3).
Additionally, 1 AT was a re-entry around the right atrial
post-atriotomy scar (Online Fig. 2). Ten of 27 (37%)
re-entrant ATs (5 perimitral, 3 roof-dependent, and 2 cavo-
tricuspid isthmus-dependent AT) were observed in patients
who had had previous AF ablation (including linear lesions
in 7 patients).
Overall, ECM accurately diagnosed 85% of the re-entrant
AT. The diagnostic accuracy of ECM for the cavotricuspid
isthmus- and roof-dependent AT and the post-atriotomy scar-
related ATwas found to be 100%. One of 5 perimitral AT cases
was diagnosed accurately on ECM. In the rest, no deﬁnite
pattern (focal or re-entry) emerged on the analysis of ECM
during AT except for counterclockwise (superior to inferior)
Figure 2 Perimitral AT
(A) A 12-lead electrocardiogram of clinical tachycardia. (B) An isochronal activation electrocardiomap of clockwise perimitral AT. Typically, the coronary sinus and contiguous
posterior-inferior left atrium are activated from lateral to septal direction and the Bachmann bundle activation proceeds in the opposite direction, covering almost the entire
tachycardia cycle length. The morphology of the virtual unipolar electrograms displayed from 6 atrial sites distributed around the mitral annulus conﬁrms the activation pattern.
The right atrial free wall is typically activated from above downward during perimitral AT. The cavotricuspid isthmus is activated laterally (toward the right atrial free wall) from the
septum (coronary sinus ostium level) without substantial conduction delay conﬁrming the bystander role of the right atrium in perimitral AT. Online Video 2 shows an isopotential
map of this AT. (C) Intracardiac electrograms from the lateral mitral isthmus and coronary sinus recorded during the ablation of perimitral AT. (D) Postero-anterior ﬂuoroscopic
image showing the location of intracardiac catheters. Abbreviations as in Figure 1.
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893activation of right atrial lateral wall. These were our initial cases
where QRST-complex superimposition on P waves (2:1 atrio-
ventricular conduction) disallowed selection of 1 full tachycardia
cycle. This could have been potentially resolved by slowing the
ventricular rate. In addition, these were also the post-ablation
atria with substantially low tachycardia P-wave amplitudes,
which further complicated and challenged the diagnosis. The
median value of the invasive bipolar voltages in the region of
the coronary sinus was 0.2 mV (range 0.05 to 3.53 mV)
(Online Fig. 3).
CENTRIFUGAL ATRIAL TACHYCARDIA. As described, all focal
ATwere diagnosed based on the presence of centrifugal spread
of activation from a small source (11). Among 21 centrifugal
AT (Table 2), 15 originated from the left atrium (Fig. 4),
4 from the right (Fig. 5), and 2 from interatrial septum
(Online Fig. 4). The atrial distribution of the centrifugal
sites is illustrated in Online Figure 2. Thirteen (62%) centrif-
ugal AT were associated with previous AF ablation.Left atrium source. ECM correctly diagnosed all left atrial
centrifugal AT. Among the 7 AT originating anteriorly in the
left atrium, 3 originated from the anterior wall, 2 from the
appendage, 1 from the junction of the left atrium and the
appendage, and 1 from the anterior left superior pulmonary
venous ostial region. Among the 8 AT originating posteriorly in
the left atrium, 5 were located at the pulmonary venous ostia (left
superior: 2, right superior: 1, left inferior: 1, right inferior: 1), 1 on
the roof, 1 at the junction of roof with right superior pulmonary
venous ostium, and 1 on the posterior wall at the site of left
inferior vein suture inapatientwithbilateral pulmonary transplant.
Right atrium source. ECM correctly diagnosed all right
atrial centrifugal AT. Among 4 right atrial sources, 1 AT
originated below the location of the sino-atrial node posteriorly,
1 from the ostial superior vena cava, 1 from the cavotricuspid
isthmus, and 1 anterolaterally in the free wall (Fig. 5).
Interatrial septum source. Between the 2 septal centrifugal
ATdiagnosed onECM, 1 arose from the septumnear the fossa
Figure 3 Left Atrial Roof-Dependent AT
(A) A 12-lead electrocardiogram of clinical tachycardia. (B) An isochronal activation electrocardiomap of a typical macro–re-entrant roof-dependent AT. The below upward
activation of the anterior wall of the left atrium is shown on the left and the top to bottom activation of the posterior left atrium is shown on the right. The bystander right atrial
free wall is activated from above downward. The entire tachycardia cycle length is covered along the AT circuit and the morphology of the virtual unipolar electrograms displayed
from 5 atrial sites distributed along the trajectory of the macro–re-entry concur with this activation pattern. Online Video 3 shows an isopotential map of this AT. (C) Intracardiac
electrograms from the left atrial roof and coronary sinus recorded during the ablation of roof-dependent AT. (D) Postero-anterior ﬂuoroscopic image showing the location of
intracardiac catheters. IVC ¼ inferior vena cava; LIPV ¼ left inferior pulmonary vein; RIPV ¼ right inferior pulmonary vein; RSPV ¼ right superior pulmonary vein; other abbre-
viations as in Figure 1.
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894ovalis, and 1 from the superior left atrial septum. Whereas the
source was not directly visualized on the biatrial map, a septal
mechanismwas deduced from the earliest epicardial exit, which
was observed at the anterior interatrial groove. An example is
shown in Online Figure 4, where an inferior interatrial groove
breakthrough occurs 11 ms after the P-wave onset, and this is
followed within a short interval (27 ms) by a superior atrial roof
breakthrough due to the septal focal wave front propagating
superiorly through the septum. ECM correctly diagnosed both
septal centrifugal AT.
PREVIOUS ABLATION PROCEDURE AND ECM ACCURACY. The
diagnostic accuracy of ECM in patients with previous AF
ablation was 83% (19 of 23 AT). In the remaining 25 cases
without any previous atrial ablation, the diagnosis was
accurately obtained in 25 of 25 AT (100%). Two septal-source
centrifugal AT, each of which presented with epicardial exit on
the anterior interatrial groove, were also accurately diagnosed
by ECM.
Discussion
The ECM technology has been used in noninvasively
reconstructing the electrophysiological properties of the heart
in structurally normal and diseased hearts (12–16). In this
study, we demonstrate the clinical utility of this external,
single-beat 3D mapping system in mapping simple andcomplex AT. The overall diagnostic accuracy of ECM
compared with invasive EP diagnosis, as the gold standard,
was 92% (100% in patients with de novo ablations and 83%
in patients with previous AF ablations). ECM was partic-
ularly useful and adept at accurately diagnosing centrifugal
AT in 100% of patients, including 13 (62%) patients with
previous AF ablation. Among the patients with centrifugal
AT, differentiation of true focal from localized (not macro)
re-entrant AT could not be established. Whereas such
differentiation may be important from a mechanistic per-
spective, it is irrelevant for identifying the clinical ablation
target (17).
Initially in this study, it was challenging to map 4 cases of
perimitral AT. The 2 primary reasons for failure were: 1) the
2:1 atrioventricular conduction, precluding selection of a full
tachycardia cycle (unmasked by QRST complex); and 2)
addition to low-voltage electrograms. Noise reduction using
a signal-averaging algorithm was very practical and clinically
useful for stable monomorphic arrhythmias without altering
the morphology or frequency content of low-amplitude
signals by traditional ﬁltering techniques. Signal averaging
could not be employed when the QRST complex obscured
the P waves. However, there are known signal-processing
techniques that can be incorporated to remove the ven-
tricular complex from obscuring the P waves, and these
warrant further development. Alternatively, administration
Figure 4 Left Atrial Focal AT
(A) A 12-lead electrocardiogram of clinical tachycardia. (B) An isochronal activation electrocardiomap of a basal left atrial appendage source centrifugal AT. The morphology of
the virtual unipolar electrogram at the source displays typical QS morphology. (C) Intracardiac electrograms from the lateral left atrium and coronary sinus recorded during the
ablation of left atrial source centrifugal AT. (D) Postero-anterior ﬂuoroscopic image showing the location of intracardiac catheters. Abbreviations as in Figure 1.
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895of atrioventricular node blockers or simple pacing maneuvers
during the invasive procedure can unmask the P waves
(i.e., post-ventricular pacing pause in the R-R interval can
allow unobscured (by QRST complex) P waves or multiple
AT cycle capture). In our recent experience with per
procedural use of the system, we have been successful in
diagnosing several clockwise and counterclockwise perimitral
AT cases with and without simultaneous roof-dependent
circuits using long R-R intervals, signal average, and other
noise-ﬁltering techniques despite low-amplitude P waves
from extensive atrial ablation.
Study limitations. First, the system is not able to provide
direct mapping of the septum. Because the septum is not an
epicardial structure and therefore not included or displayed
on the map, a septal source can be deduced by analyzing the
location (interatrial groove) and timing of the epicardial
breakthrough. Second, ECM provides epicardial maps.
Although there is experimental evidence for differential
activation of the contiguous endo-epicardium in the atria (in
at least some of its parts), the difference may be considered
modest, at best, or even negligible in this multicenter study,
where there was virtually no difference between the epicar-
dial ECM and endocardial targets of ablation, as evidenced
in Online Figure 5 and previously published reports (12,13).
Indeed, the atrial tissue is much thinner (in most parts)than the ventricular myocardium is, and evaluating the
quantitative resolution of the system was beyond the scope of
this study. Third, AT with 2:1 conduction to the ventricles
pose an analytic challenge in the absence of reliable QRST-
subtraction software program. The use of atrioventricular
node blockers is strongly recommended in this situation.
Fourth, AT with low signal-to-noise ratio may be chal-
lenging to analyze. Further development of signal processing
techniques, including averaging and appropriate ﬁltering,
has helped improve the accuracy of diagnosis in such situ-
ations as successfully evaluated in successive patients.
Clinical perspectives. First, ECM is a novel tool that
noninvasively provides global atrial activation patterns of
sustained as well as transient AT from a single tachycardia
beat per cycle. On the other hand, current sequential beat
mapping techniques necessitates sustenance of AT or
repetitive occurrence of ectopic beats, making the approach
impractical in nonsustained AT. Single-beat, simultaneous
mapping can be crucial when the clinical AT frequently
changes from 1 form to another and back and also for
mapping the beats, which trigger sustained arrhythmias such
as AF. Such a beat-to-beat analysis allows tracking of the
changes, which may arise spontaneously or after ablation.
Being a noninvasive system, ECM is a mapping technology
that can be applied bedside, potentially providing the EP
Figure 5 Right Atrial Focal Atrial Ectopy
(A) A 12-lead electrocardiogram of clinical tachycardia shows ectopic beats. (B) An isochronal activation electrocardiomaps (in 2 views) of a right atrial free-wall source
centrifugal AT (ectopy). The morphology of the virtual unipolar electrogram at the source displays typical QS morphology. (C) Intracardiac electrograms from the right atrial free
wall and coronary sinus recorded during the ablation of right atrial ectopic source. (D) Postero-anterior ﬂuoroscopic image showing the location of intracardiac catheters.
Abbreviations as in Figures 1 and 3.
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896physician with more data to plan the ablation procedure.
Quantiﬁcation of the clinical impact of ECM in saving
procedure time, ﬂuoroscopic exposure, and, in general, the
efﬁcacy of the ablation procedure is a logical next step.
Second, real-time panoramic mapping, progress in computer
technology, and new signal processing will add further
advantages over conventional ECG and enhance the utility
of the current system beyond global atrial activation and
tissue-level information like local electrograms (i.e.,
morphology) and voltage.
Conclusions
This multicenter experience with novel, noninvasive
mapping system in a wide range of patients demonstrates the
feasibility of accurately identifying the atria where the AT is
located and deﬁning the AT mechanism. This study
demonstrates the clinical utility of the system in the
noninvasive diagnosis of various atrial tachycardias. The
rapid (single beat per cycle) mapping and reliable diagnostic
ability of the system underscore its potential to reduce
ablation and procedural times and suggests its potential role
in mapping rapidly changing arrhythmias such as AF.
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